Osteonecrosis of the jaw (ONJ) is a serious complication for physicians prescribing bone resorption inhibitors to patients with osteoporosis. A session at the recent French Congress of Rheumatology ...

The Phase II study was extended up to 36 months. At this time, increases in BMD achieved were similar to those of most powerful antiresorptive agents (zoledronate and denosumab), but with differences ...

Clinicians and researchers meet to learn about new research and the latest clinical advances at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases Bone and musculoskeletal ...

A University of Massachusetts Amherst researcher has received funding from the National Cancer Institute (NCI) to study the complex relationship between drugs used to treat metastatic cancer and the ...

In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme that controls the activity of osteoblasts. An ...